YXU-31818-63206 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-29
Registered in v-safe
2020-12-29
Dose 1 — Moderna
2020-12-29
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2020-12-30
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-31
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-03
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-04
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-05
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-14
Survey response — day 14, dose 1
MedDRA: Injection site erythema, Injection site swelling — Feeling: Good

Free text: Large red swollen area (11 Cm x 5 cm) at injection site - one week after injection. That lasted for several days.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-19
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-01-26
Health check-in — day 28, dose 1
Feeling: Good

Adult check-in
2021-01-30
Dose 2 — Moderna
2021-02-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-02-03
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Swelling · None

Adult check-in
2021-02-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-05
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-06
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-02-13
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-20
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-07-31
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-30
Survey response — 12 months, dose 2
MedDRA: Urticaria chronic — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Chronic uticaria

MedDRA releases: 2024-11 · check-in free text available
2022-01-30
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-03-24
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-29	Moderna
2	2021-01-30	Moderna

Call center

Reported	Outcome	VAERS-related outcome
2022-01-30	Unsuccessful

Free text

Release 2 — day 14, dose 1

2021-01-14

Symptoms: Large red swollen area (11 Cm x 5 cm) at injection site - one week after injection. That lasted for several days.

Release 11 — 12 months, dose 2

2022-01-30

Symptoms: Chronic uticaria

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Injection site erythema	✓	✓	✓
SD	Injection site swelling	✓	✓	✓
SD	Urticaria chronic	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release